ADXS stock news

Thinly traded micro cap Advaxis (ADXS) is up 39% premarket on robust volume in response to updated data from an open-label Phase 1/2 clinical trial, KEYNOT Read more
Thinly traded micro cap Advaxis (ADXS) is up 39% premarket on robust volume in response to updated data from an open-label Phase 1/2 clinical trial, KEYNOT Read more
Investors have many things to keep an eye on when trading the equity market. Riding through the ups and downs that come with market volatility may take some getting used to for beginners. Even if the Read more
Advaxis Inc. (NASDAQ:ADXS) and Moderna Inc. (NASDAQ:MRNA) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as institutional Read more
Advaxis Inc. (NASDAQ:ADXS) and Novo Nordisk A/S (NYSE:NVO) compete with each other in the Biotechnology sector. We will analyze and contrast their risk, analyst recommendations, profitability, dividen Read more
Advaxis Inc (ADXS)’s moving averages reveal that the Tenkan line of the shares are below the Kijun-Sen line, indicating potential downward momentum building in the bearish chart. Advaxis Inc moved 0 Read more
As Biotechnology companies, Advaxis Inc. (NASDAQ:ADXS) and Heat Biologics Inc. (NASDAQ:HTBX) are our subject to compare. And more specifically their institutional ownership, earnings and valuation, pr Read more
Advaxis Inc. (NASDAQ:ADXS) and Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, institutional Read more
The Return on Invested Capital (aka ROIC) Score for Advaxis, Inc. (NasdaqGS:ADXS) is -1.771787. The Return on Invested Capital is a ratio that reveals whether a company is profitable or not. It shows Read more
As Biotechnology companies, Advaxis Inc. (NASDAQ:ADXS) and Capricor Therapeutics Inc. (NASDAQ:CAPR) are our subject to contrast. And more specifically their risk, analyst recommendations, profitabilit Read more
Advaxis Inc. (NASDAQ:ADXS) and Intrexon Corporation (NASDAQ:XON) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as risk, i Read more
As Biotechnology companies, Advaxis Inc. (NASDAQ:ADXS) and BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) are our subject to compare. And more specifically their profitability, analyst recommendations, r Read more
When setting up a personal stock investment strategy, individual investors often set short-term and long-term goals. These goals may address the questions of specific objectives, how to start achievin Read more
ValuEngine upgraded shares of Advaxis (NASDAQ:ADXS) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday, ValuEngine reports. Several other equities analysts hav Read more

Proudly made at

ROCKIT